In
vitro Anti-Alzheimer and Anti Oxidant
activity of the Peels of Citrus maxima fruits
P. Vijayalakshmi*, R. Radha
Department of Pharmacognosy, College of Pharmacy,
Madras Medical College, Chennai – 600003
*Corresponding Author E-mail: vijayapharma7@gmail.com
ABSTRACT:
Alzheimer’s disease is an age-associated,
irreversible, progressive neurodegenerative disease which is characterized by
severe memory loss, unusual behavior, personality changes, and a decline in
cognitive function. Even today Alzheimer disease is spreading in very fast pace though large
number of researchers and manufacturers are engaged to find effective
medication but result is not satisfactory. Most of the drugs or medicines have
high tendency of side effect. This fact made me inclined towards plants to
execute the research work. Normally it is observed that side effects in plant
derivative are very less. Most potential target for the treatment and slowing
down of Alzheimer disease progression is cholinesterase inhibitors from plants.
The anti oxidant and anti cholinesterase activity of various extracts of Citrus maxima fruit peels were studied
by DPPH assay and Hydrogen Peroxide radical scavenging effect for in vitro analysis; Whereas Ellman’s colorimetric methods were used for anti
cholinesterase activity estimation. Ethanolic extract
shown the potent anti oxidant (DPPH; IC50= 25 µg/ml , HPSA; IC50=
54 µg/ml ) and anti cholinesterase activity with IC50 value
of 115µg/ml.
These plants were found to be potent enough to be
studied further for its in vivo Anti
Alzheimer disease and to perform formulations.
KEYWORDS: Alzheimer
disease, Citrus maxima, anti oxidant,
anti cholinesterase activity.
INTRODUCTION:
Alzhiemer’s or Alzhiemer disease accounts for
about 60 to 70% of cases of
dementia. It is a chronic neurodegenerative disease that usually starts slowly
and gets worse over time1,2.
It is a peculiar disease of cerebral cortex identified
by Dr. Alios Alzheimer in 1906 and was later named as
Alzheimer’s disease3. It is
described as thin cortex speckled with usual brown clumps and irregular knots
that was found to be growing inside the brain cells and are now known as amyloid plaques and neurofibrillary
tangles. The brains of people with AD have
been found to have abundant of two abnormal structures. Amyloid
plagues and neurofibrillary tangles which are made of
misfolded proteins. Diagnosed in both the gender over
65 years of age4.
In 2006 26.6
million people of age more than 65 years was found to be affected by AD (Alzheimer’s
disease). It was predicted to affect 1
in 85 people globally by 20505. The symptoms of Alzheimer’s disease
is unique for every individual6.
AD is diagnosis confirmed with behavioral assessments, cognitive
tests and followed by brain scan7.
Recently researchers have found that activity-dependent
neuroprotective protein (ADNP) in elderly individuals
can assess the patients at risk for Alzheimer's disease. ANDP levels in blood
and amyloid plaques (a hallmark Alzheimer's) in the
brain," said lead researcher Illana Gozes from Tel Aviv University in Israel.
Several biochemical and pathological
mechanism contribute to AD. These include (i).
Imbalance in production of amyloid β (Aβ) vs its clearance
resulting in accumulation of Aβ in the form of
senile plaques (Amyloid hypothesis)8.
These plaques can induce neuroinflammatory process
and trigger the production reactive oxygen species9. ( ii)
Cholinergic deficits resulting due to enhanced activity of acetylcholinesterase
and Butyl cholinesterase, contributing to the cognitive impairments seen in AD
(Cholinergic hypothesis)10. Based on those hypotheses several anti
amyloid11 and cholinesterase inhibitor12 are investigated
for their disease modifying stratergies
Plant have been a major source of
medicine. About
80% of the population in developing countries yet relies on plant based
medicines to obtain primary health care WHO 197813.
Citrus maxima (Linn) of family Rutacea
commonly known as Pamelo, Pomelo,
Sadhaphal etc. It was traditionally used in Epilepsy,
cholera, Cough, Asthma etc14. It has been evaluated for its anti
diabetic15 , CNS activity16, Hypocholestremic
activity17, Analgesic, anti inflammatory18, anti
depressant19, anti tumor20,anti oxidant activity of
leaves21 , using various parts of plant. The present study is on the
in vitro anti oxidant and in vitro anti alzheimer
activity of the dried peels of Citrus
maxima.
MATERIAL
AND METHODS:
Plant Material
Citrus maxima fruits were collected from Cuddalore (Tamil Nadu) in June and July 2015. The plant was
authenticated for its identity by Scientist F and Head of office Dr. G.V.S. Muruthy Botanical Survey of India, Coimbatore with survey
no: BSI/SR/5/23/2016/Tech/33. It was identified as Citrus maxima (Burm.) Merr.
(= Aurantium
maximum Burm.)-Rutaceae
Preparation of samples
The Peels of fruit Citrus
maxima were shade dried, cut into
pieces, powdered and was stored in the air tight container and a portion of it
is used for the Pharmacognostical and Phytochemical studies and remaining it was extracted.
Extraction
Plant material was dried in shadow and ground to
powder for extraction. The extraction was done using Soxhlet apparatus and extracted
with the solvents of increasing polarity like Hexane, Ethyl acetate, ethanol
and was macerated with water at the end of soxhlet
extraction.
In Vitro Anti oxidant
In vitro antioxidant activities for the extracts
were carried out using the following methods.
1. DPPH assay
2. Hydrogen peroxide scavenging assay.
DPPH Assay: 1, 2-Diphenyl-2-picryl hydrazyl
Radical (DPPH)22
Initial volume 0.1 mL of
various concentrations of samples was mixed with 0.4 mL
of 0.3M DPPH reagent prepared in ethanol. The mixture was shaken thoroughly and
incubated in the darkness at room temperature for 30 min. The absorbance of the
reaction was measured spectrophotometrically at 517nm, immediately after mixing
and then after incubation as well. The scavenging effect of DPPH free radical
was calculated by using the following equation.
% Scavenging activity =
Abs (control) - Abs (standard) / Abs (control) × 100
Where control is the absorbance of the blank (a
reaction with all the reagents except the test extract), and absorbance of
sample is the absorbance of the test extract. Tests were carried out in
triplicates to obtain 50% inhibition (IC50). Using Butylated
hydroxy Toulene.
Hydrogen Peroxide Scavenging
Assay (HPSA)23
The ability of the extracts to scavenge hydrogen peroxide was determined according to the
method of Ruch. A solution of Hydrogen peroxide
(2mmol/l\lt) was prepared in phosphate buffer (PH
7.4). Various concentrations of extracts (10-100µg/ml) were added to hydrogen
peroxide solution (0.6ml). Absorbance at
230nm was determined after 10min against a blank solution containing phosphate
buffer without hydrogen peroxide.
% Scavenging activity =
Abs (control) - Abs (standard) / Abs (control) × 100
Compared with the ascorbic acid standard.
Anti-Acetylcholinesterase
Assay24
The enzymatic activity was determined by Ellman’s methods developed in year 1961. It is used to
measure extract for its Ache inhibition. Electric cell was considered as the
enzyme source, acetyl thiocholine iodide was used as
substrate and 5, 5, bis dithionitrobenzene,
a dye was used for the measurement of cholinesterase activity.
In this assay, 150 µl of 0.1M sodium phosphate buffer
(pH 8), 10 µl of test compound solution and 20µl of enzyme solution (0.09
units/ml) were mixed and incubated at 250c for 15 min. 10 µl of the
DTNB solution, 10 µl of acetyl thiocholine iodide
were added to the resultant and allowed to withstand for 10 min. The intensity
of the colour produced were studied using spectrophotometric observation at 410 nm. Physostigmine dissolved in ethanol is used as a standard.
Percentage of enzyme inhibition was determined using the formula below
% Enzyme inhibition =
[(Optical density
of test-blank) X 100]
Optical density of
standard-blank
Statistical analysis:
All determinations were done for three times and
results reported as mean ± Standard deviation. IC50 values were
calculated and reported.
RESULT
AND DISCUSSION:
Antioxidant activities
A number of studies shown that oxidative stress is
involved in age related neurodegenerative diseases. Likewise, there are
numerous studies which have examined the positive benefits of antioxidants to
reduce or block neuronal death occurring in the pathophysiology
of these disorder. In addition, the antioxidant potential of a compound can be
attributed to its radical scavenging ability and total antioxidant activity. In
order to determine the ability of the plant extracts to serve as antioxidants,
two activities were measured; ability to scavenge DPPH and Hydrogen Peroxide Scavenging assay.
DPPH radical scavenging
activity :
Various extracts were studied for its anti oxidant
activity using 1, 2-diphenyl-2-picryl hydrazyl
radical (DPPH). Results are discussed in Table 1 and Fig 1.
Table 1: DPPH Radical Scavenging
activity of various extract
S.No |
Concentration (µg/ml) |
% Inhibition |
||||
Standard (Butylated hydroxyl Toulene
) |
Hexane |
Ethyl acetate |
Ethanol |
Aqueous |
||
1. |
20 |
53.95 |
19.43 |
23.61 |
45.94 |
19.34 |
2. |
40 |
64.81 |
29.32 |
31.28 |
59.86 |
29.34 |
3. |
60 |
76.62 |
30.54 |
33.59 |
68.18 |
30.34 |
4. |
80 |
85.21 |
31.34 |
43.16 |
76.95 |
34.32 |
5 |
100 |
91.45 |
37.34 |
52.23 |
88.87 |
37.45 |
IC50 (µg/ml) |
10 |
152 |
97 |
25 |
147 |
Fig 1: DPPH Radical Scavenging
activity of various extract
The DPPH is a stable free radical which produced deep
purple colour by accepting the proton from any proton
donor substance and widely used to test free radical scavenging effect. The
reduction of DPPH decreases its absorbance at 517 nm due to colour
change. The ethanolic extract of Citrus maxima peel showed IC50 value (µg/ml) of 25 where
as Hexane, Ethyl acetate and aqueous extract showed Ic50 (µg/ml)
value 152, 97, 147 respectively. Whereas the IC50 (µg/ml) value of
standard BHT was 10. Ethanolic extracts of Citrus maxima peel are found to produce
good scavenging activity in comparison to standard.
Hydrogen Peroxide Radical
Scavenging Activity:
The Hexane, ethyl acetate, ethanol and aqueous
extracts were subjected to hydrogen peroxide radical scavenging assay and the
results are tabulated below in Table 2 and Fig 2.
Table 2: Hydrogen peroxide
Radical Scavenging activity of various extract
S no |
Concentration |
% inhibition |
||||
Standard (Ascorbic acid) |
Hexane |
Ethyl acetate |
Ethanol |
Aqueous |
||
1 |
20 µg/ml |
32.23 |
16.43 |
36.51 |
40.43 |
12.34 |
2 |
40 µg/ml |
38.13 |
20.32 |
42.23 |
45.65 |
24.54 |
3 |
60 µg/ml |
56.34 |
23.34 |
46.43 |
50.81 |
28.45 |
4 |
80 µg/ml |
73.32 |
29.34 |
52.34 |
57.65 |
32.54 |
5 |
100 µg/ml |
88.34 |
43.23 |
53.43 |
65.56 |
38.56 |
IC 50 (µg/ml) |
47 |
127 |
77 |
54 |
131 |
Fig 2: Hydrogen peroxide
Radical Scavenging activity of various extract
The ability of the extract to scavenge hydrogen
peroxide was determined in this method. Absorbance is measured at 230 nm and IC50
(µg/ml) value has been calculated and was found to be 54 for Ethanol,
Were as Hexane, Ethyl acetate and Aqueous extract showed the IC50 –value
(µg/ml) of 127,77 and 131 respectively. IC50 value of standard
Ascorbic acid was 47.
Ethanolic extract of Citrus
maxima peel was found to produce good scavenging activity in comparison to
standard.
Anti-Acetylcholinesterase
Assay
In vitro assay were performed on various extracts to
select the extract for the further studies. In this assay the percentage
inhibition were noticed for all the fractions. The extract with least IC50
value shows good inhibition. The result are tabulated below in Table no:
3.
The ethanolic extract of Citrus maxima peel shown good enzyme
inhibition activity. Hence they were subjected to in vivo Pharmacological studies and result are tabulated in Table 3
and plotted in Fig 3.
Table 3: Acetyl cholinesterase
assay of various extract
Extract |
IC50 value |
Hexane extract |
215 µg/ml |
Ethyl acetate extract |
159 µg/ml |
Ethanol extract |
115 µg/ml |
Aqueous extract |
950µg/ml |
Fig 3: Acetyl cholinesterase
assay of various extract
The acetyl cholinesterase enzyme is a biomarker in
amnesia. In this assay the percentage enzyme inhibition has been recorded for
all the extracts. The ethanolic extract shown IC50
value of 115 µg/ml were the hexane, ethyl acetate, aqueous extract shown the IC50(µg/ml)
value of 215, 159 and 950 respectively. It was observed that all the
extract posses inhibitory activity against AChE, but ethanolic extract of Citrus
maxima had good AChE inhibitory activity. Ethanol
used as a solvent and it produced better activity as compared to aqueous is
described in various reports25. The higher activity of the ethanolic extract may be due the organic solvents which are
able to extract compounds with higher AChE inhibitory
activity26. Thus the ethanolic extract can
be used for the further studies.
CONCLUSION:
The study included in
vitro anti oxidant and in vitro AChE inhibitory activity of the various extracts of Citrus maxima. Ethanolic
extract of Citrus maxima fruit peels
were found to show good radical scavenging activity in dose dependent manner. In vitro acetyl cholinesterase enzyme
inhibition study by modified Ellman’s method confirms
that the ethanolic extract of Citrus maxima maximum inhibition while comparing the IC50 Values
of all extracts. Thus these extract have good anti oxidant potency and AchE inhibitory activity. It has thus paved a new path for
an alternative anti oxidant and AChE inhibitor and futher in vivo studies
could be carried out based on these reports.
REFERENCES:
1.
Burns A, Iliffe S (5
February 2009). "Alzheimer's disease". BMJ 338: b158.
2.
"Dementia
Fact sheet N°362". World Health Organization. March 2015.
Retrieved 13 January 2016.
3.
Alzheimer’s disease and Dementia. A Guide For Adult
Protective Services Workers. available at http://www.dcf.state.fl.us/programs/ aps/docs/ Dementia Pamphlet. Pdf
4.
Brookmeyer R., Gray S., Kawas C. (September 1998). "Projections of Alzheimer's
disease in the United States and the public health impact of delaying disease
onset". American Journal of Public Health 88 (9): 1337–42.
5.
Brookmeyer, R; Johnson, E;
Ziegler- Graham, K; Arrighi, HM (July 2007).
"Forecasting the global burden of Alzheimer's disease". Alzheimer's
and Dementia 3 (3): 186–91
6.
"What is Alzheimer's disease?".
Alzheimers.org.uk. August 2007.
http://www.alzheimers.org.uk/site/scripts/documents_info.php?document ID=100
Retrieved 2008-02-21.
7.
"Alzheimer's diagnosis of AD”. Alzheimer’s
Research Trust. http://www.alzheimersresearch.org.uk/info/diagnosis/. Retrieved
2008-02-29.
8.
Hardy J and Selkoe D J,
The amyloid hypothesis of Alzheimer’s disease:
Progress and problems on the road to therapeutics, science, 297 (2002) 353.
9.
Vina J, Lloret A, Orti R and Alonso D,
Molecular basis of the treatment of Alzhiemer’s
disease with antioxidants: Prevention of oxidative stress, Mol, Aspects meds 25 (2004)117.
10.
Craig L A, Hong N S, Mc Donald R J, Revisiting the
cholinergic hypothesis in the development of Alzhiemer’s
disease. Neurosci behave Rev, 35 (2011) 1397.
11.
Schenk D, Basi G S, Pangalos M N,
Treatment strategies targeting Amyloid-β protein
Cold spring Harb Perpect
Med, 2 (2012) a006387.
12.
Mehta M, Adem A and Sabbagh M, acetyl cholinesterase inhibitors for Alzheimer’s
disease, International Journal on Alzheimer’s Disease (2012) article ID 728983.
13. Dubey NK, Rajesh Kumar, Parimila Tripathi, Global
promotion of herbal medicines: India’s Opportunity, Current Science. 2004, 86
(1), 37-41.
14. Kritikar, K.R., and Basu,
B.D, Indian medicinal plants, Vol-I, International
Book Distributors, 2008, 495-496.
15.
Abdul Muneer MT , Ashok Shenoy, Karunakar Hegde, Sayed Aamer
and AR. Shabaraya: Evaluation of the Anti-diabetic
Activity of Ethanolic Extract of Citrus maxima Stem Bark. International Journal Of Pharmaceutical
And Chemical Sciences. Jul-Sep 2014,
Vol. 3 (3). 642-650.
16.
Haja Sherief Sheik, Niraimathi Vedhaiyan, Sengottuvelu Singaravel. Evaluation of Central Nervous System Activities
of Citrus maxima Leaf Extract on Rodents.
J App Pharm Sci, 2014; 4 (09):
077-082.
17.
Ganiyu Oboh, Fatai O. Bello, Ayokunle O. Ademosun: Hypocholesterolemic properties of grapefruit(Citrus paradisii) and shaddock (Citrus maxima) juices and inhibition
of angiotensin-1-converting enzyme
activity. journal of food and drug analysis 22 (2014)477 -484.
18.
Shivananda A, Muralidhara Rao D, And Jayaveera Kn, Analgesic And
Anti-Inflammatory Activities Of Citrus Maxima (J.Burm)
Merr In Animal Models. Research Journal of
Pharmaceutical, Biological and Chemical Sciences 2013, 4(2); 1800-1810.
19.
Vikram H Potdar, and Swati J Kibile: Evaluation of
Antidepressant-like Effect of Citrus
Maxima Leaves in Animal Models of Depression Iran Journal Basic Med
Sci. 2011 Sep-Oct; 14(5): 478–483.
20.
Sriparna KunduSen, Malaya Gupta, Upal K. Mazumder, Pallab K. Haldar, Prerona Saha, and Asis Bala Antitumor Activity
of Citrus maxima (Burm.) Merr. Leaves in Ehrlich's Ascites
Carcinoma Cell-Treated Mice ISRN Pharmacology 2011.
21.
Pallab K Haldar . Sriparna Kundusen , Malaya Gupta, Upal K Mazumder , Siva P Panda and Sanjib
Bhattacharya Evaluation Of In Vitro Antioxidant
Activity Of Citrus Limetta
And Citrus Maxima On Reactive
Oxygen And Nitrogen Species Pharmacologyonline (2010),
3: 850-857 .
22.
Blois M.S. Antioxidant determination by the use of
table free radical. Nature. 1958. 29: 1199-2000.
23.
Prashant R.Kaldhone., Yadunath M.joshi, Vilasrao J. Kadam and Prashanth R. Kaldhone studies on
in-vitro Antioxidant activity of methanolic extract
of aerial parts of Canna indica L. Journal of pharmacy research 2009,2(11):
pg.no.1712-1715.
24.
Tepe B, Daferera D, Sokmen A, Sokmen M, Polissiou M.
Antimicrobial and antioxidant activities of essential oil and various extracts
of Salvia tomentosa Miller (Lamiaceae).
Food Chem 2005; 90:333–340.
25.
Adewusi EA, Moodley N, Steenkamp V.
Antioxidant and acetylcholinesterase inhibitory
activity of selected southern African medicinal plants. S Afr
J of Bot 2011; 3:638–644.
26.
Deepak G, Silviya S, Kishwar HK. Biochemical compositions and antibacterial
activities of Lantana camara
plants with yellow, lavender, red and white flowers. Eurasia J Biosci 2009; 3:69-77.
Received on
17.02.2016 Modified
on 05.03.2016
Accepted on 15.03.2016
©A&V Publications All right reserved
Res. J.
Pharmacology & P’dynamics. 8(1): Jan.-Mar., 2016;
Page 17-22
DOI: 10.5958/2321-5836.2016.00005.7